MENU
BRVE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Braveheart Bio (BRVE) Earnings Date & Reports
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases... Show more
A.I. Advisor
published Earnings
BRVE is expected to report earnings to fall 63.75% to -91 cents per share on December 08
Q3'26
Est.
$-0.91
Q2'26
Missed
by $2.26
The last earnings report on September 08 showed earnings per share of -250 cents, missing the estimate of -25 cents. With 225.50K shares outstanding, the current market capitalization sits at 1.67B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
One Letterman Drive
Phone
+1 415 707-6312
Employees
30
Web
https://www.braveheart.bio